PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsventricular tachycardia
MeSH D017180 - ventricular tachycardia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D013610:Tachycardia
0 Companies
0 Drugs
Success rate
D017180: 
Ventricular tachycardia
D016170:Accelerated idioventricular rhythm
0 Companies
0 Drugs
Success rate
D016171:Torsades de pointes
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAtenolol Atenolol  1993-05-28   
Lidocaine, Prilocaine Emla  1992-12-30   
Epinephrine Epinephrine  2018-08-16   
Lidocaine Lidocaine  2018-01-16   
Metoprolol Metoprolol  1994-09-30   
Procainamide Procainamide  1982-01-01   
Propranolol Propranolol  1987-10-07   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1988-12-01   
Sotalol Sotalol  2000-05-01   
Novast LaboratoriesMetoprolol Metoprolol  2018-02-06   
PadagisLidocaine, Prilocaine Lidocaine Prilocaine  2021-07-27   
Taro PharmaceuticalLidocaine Lidocaine  1982-01-01   
Lidocaine, Tetracaine Pliaglis 2031-01-14 2006-06-29   
Glenmark PharmaceuticalsLidocaine Lidocaine  2016-09-09   
MylanAtenolol Atenolol  1992-01-24   
Epinephrine Epi 2025-09-11 1987-12-22   
Lidocaine Lidocaine  2015-08-07   
Metoprolol Metoprolol  1993-12-21   
Hydrochlorothiazide, Metoprolol Metoprolol Hydrochlorothiazide  2004-08-20   
Propranolol Propranolol  1985-11-19   
Rising PharmaceuticalsLidocaine Lidocaine  2010-09-27   
Propranolol Propranolol  2007-02-15   
Sotalol Sotalol  2000-12-19   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1987-03-04   
RocheCeftriaxone, Lidocaine Rocephin  1984-12-21 $261.442 M Y2021 
Armstrong PharmaceuticalsEpinephrine Epinephrine  1984-05-23   
Epinephrine Primatene Mist 2026-01-26 2018-11-07   
CiplaMetoprolol Metoprolol  2018-10-26   
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
100%
2/2
Phase 2
71%
10/14
Phase 3
69%
20/29
Approved: 13Overall Success rate: 49%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
...
10
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use